04.01.03
Sigma-tau HealthScience has been awarded U.S. patent No. 6,485,741, which involves the application of a coating to L-carnitine base particles with specialized food grade granulating/bonding agents. The process results in a particle that is most favorably suitable for conversion into solid administration forms that require a very high concentration of L-carnitine, up to 94%, particularly in the form of tablets. The resulting powder is also suitable for constituting the content of hard and soft gelatin capsules and for blended powders in sachets. The product will be marketed as CarniShield™ B94.
